5 Simple Techniques For Antidepressant agent 5
MI-CP151 was a period 1b randomised, double-blind, placebo managed, dose-escalation, multicentre study to evaluate numerous intravenous doses of sifalimumab, in adult clients with dermatomyositis or polymyositis (NCT00533091). Primary demo aims were being To judge the protection and tolerability of sifalimumab in dermatomyositis or polymyositis cli